E. Ghoos

JNJ-26070109 [(R)4-Bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: A Novel, Potent, and Selective Cholecystokinin 2 Receptor Antagonist with Good Oral Bioavailability

J. Pyati, T. Barrett, N. Shankley, 2011, Journal of Pharmacology and Experimental Therapeutics.

Effects of flunarizine on the distribution of calcium in vascular smooth muscle.

M. Borgers, J. van Nueten, F. Thoné, 1980, Blood vessels.

Stimulation of gastroduodenal motor activity: Dopaminergic and cholinergic modulation

J. Schuurkes, J. van Nueten, L. Helsen, 1986 .